Evaluation of alum-based adjuvant on the immunogenicity of salmonella enterica serovar typhi conjugates vaccines

References

• Everest P, Wain J, Roberts M, Rook G, Dougan G. The molecular mechanisms of severe typhoid fever. Trends Microbiol. 2001;9:316–20. doi:10.1016/S0966-842X(01)02067-4. PMID:11435104
   PubMed Web of Science ®Google Scholar
• Mogasale V, Maskery B, Ochiai RL, Lee JS, Mogasale VV, Ramani E, Kim YE, Park JK. Burden of typhoid fever in low-income and middle-income countries: A systematic, literature-based update with risk-factor adjustment. Lancet Glob Heal. 2014;2:570–80. doi:10.1016/S2214-109X(14)70301-8.
   PubMed Web of Science ®Google Scholar
• Ochiai RL, Acosta CJ, Danovaro-Holliday MC, Baiqing D, Bhattacharya SK, Agtini MD, Bhutta ZA, Canh DG, Ali M, Shin S, et al. A study of typhoid fever in five Asian countries: Disease burden and implications for controls. Bull World Health Organ. 2008;86:260–8. doi:10.2471/BLT.06.039818. PMID:18438514
   PubMed Web of Science ®Google Scholar
• Bajracharya D, Khan MI, Pach A, Shrestha P, Joshi N, Upreti SR, Wierzba T, Puri M, Sahastrabuddhe S, Ochiai RL. 25 Years after Vi typhoid vaccine efficacy study, typhoid affects significant number of population in Nepal. PLoS One. 2014;9. doi:10.1371/journal.pone.0077974.
   Web of Science ®Google Scholar
• Date KA, Bentsi-Enchill A, Marks F, Fox K. Typhoid fever vaccination strategies. Vaccine. 2015;33:55–61. doi:10.1016/j.vaccine.2015.04.028.
   PubMed Web of Science ®Google Scholar
• Black SB, Shinefield HR, Ray P, Lewis EM, Fireman B, Hiatt R, Madore DV, Johnson CL, Hackell JG. Safety of combined oligosaccharide conjugate Haemophilus influenzae type b (HbOC) and whole cell diphtheria-tetanus toxoids-pertussis vaccine in infancy. The Kaiser Permanente Pediatric Vaccine Study Group. Pediatr Infect Dis J. 1993;12:981–5.
   PubMed Web of Science ®Google Scholar
• Szu SC. Development of Vi Conjugate – a New Generation of Typhoid Vaccine. Expert Rev Vaccines. 2013;11:1273–86. doi:10.1586/14760584.2013.845529.
   Google Scholar
• Lin FY, Ho VA, Khiem HB, Trach DD, Bay PV, Thanh TC, Z Kossaczka Z. The Efficacy of a Salmonella Typhi Vi Conjugate Vaccine in Two-to-Five-Year-Old Children. N Engl J Med. 2001;17:1263–69. doi:10.1056/NEJM200104263441701.
   Google Scholar
• Carlsson RM, Claesson BA, Lagergard T, Kayhty H. Serum Antibodies against Haemophilus Influenzae Type B and Tetanus at 2.5 Years of Age: A Follow-up of 2 Different Regimens of Infant Vaccination. Scand J Infect Dis. 1996;5:519–23. doi:10.3109/00365549609037951.
   Google Scholar
• Elemraid MA, Rushton SP, Shirley MDF, Thomas MF, Spencer DA, Eastham KM, Hampton F. Impact of the 7-Valent Pneumococcal Conjugate Vaccine on the Incidence of Childhood Pneumonia. Epidemiol Infec. 2013;141(8):1–8.
   PubMed Web of Science ®Google Scholar
• Vesikari T, Forste´ NA, Boutriau D, Bianco V, Van der Wielen M, Miller JM. A randomized study to assess the immunogenicity, antibody persistence and safety of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in children aged 2–10 y. Hum Vaccine Immunother. 2012;8(12):1882–91.
   PubMed Web of Science ®Google Scholar
• WHO. WHO expert consultation to review evidence in support of the use of typhoid conjugate vaccines. Geneva: World Health Organization; 2014.
   Google Scholar
• Petrovsky, Nikolai, Julio CA. Vaccine Adjuvants: Current State and Future Trends. Immunol Cell Biol. 2004;82:488–96. doi:10.1111/j.0818-9641.2004.01272.x. PMID:15479434
   PubMed Web of Science ®Google Scholar
• Mohan, Teena, Priyanka V, Nageswara DR. Novel Adjuvants & Delivery Vehicles for Vaccines Development: A Road Ahead. Indian J Med Res. 2013;138:779–795 PMID:24434331
   PubMed Web of Science ®Google Scholar
• Kool M, Fierens K, Lambrecht BN. Alum adjuvant: Some of the tricks of the oldest adjuvant. J Med Microbiol. 2012;61:927–34. doi:10.1099/jmm.0.038943-0. PMID:22174375
   PubMed Web of Science ®Google Scholar
• WHO. Guideline on the nonclinical evaluation of vaccines adjuvants and adjuvanted vaccines. Geneva: World Health Organization; 2013.
   Google Scholar
• World Health Organiation. WHO prequalified vaccine: 2016. Washington (DC) [accessed:5 Mei 2017] http://www.who.int/immunization_standards/vaccine_quality/PQ_vaccine_list_en/en
   Google Scholar
• Powell, Michael F., Nguyen T, Lisa B. Compendium of Excipients for Parenteral Formulations. PDA J. Pharm. Sci. Technol. 1998;5:238–311.
   Google Scholar
• White JL, Hem SL. Characterization of Aluminium-Containing Adjuvants. Dev Biol (Basel). 2000;103:217–28 PMID:11214239
   PubMedGoogle Scholar
• WHO. Requirements for Vi polysaccharide typhoid vaccine: WHO technical report series no 849. Geneva: World Health Organization; 2014.
   Google Scholar
• Iyer, Seema, Harm H, Stanley LH. Relationship between the Degree of Antigen Adsorption to Aluminum Hydroxide Adjuvant in Interstitial Fluid and Antibody Production. Vaccine. 2003;21:1219–23. doi:10.1016/S0264-410X(02)00556-X. PMID:12559801
   PubMed Web of Science ®Google Scholar
• Toledo H, Baly A, Castro O, Resik S, Laferté J, Rolo F, Navea L, Lobaina L, Cruz O, Miguez J, et al. A phase I clinical trial of a multi-epitope polypeptide TAB9 combined with Montanide ISA 720 adjuvant in non-HIV-1 infected human volunteers. Vaccine. 2001;19:4328–36. doi:10.1016/S0264-410X(01)00111-6. PMID:11457560
   PubMed Web of Science ®Google Scholar
• McCarthy JS, Marjason J, Elliott S, Fahey P, Bang G, Malkin E, Tierney E, Aked-Huditch H, Adda C, Cross N, et al. A phase 1 trial of MSP2-C1, a blood-stage malaria vaccine containing 2 isoforms of MSP2 formulated with montanide® ISA 720. PLoS One. 2011:6. doi:10.1371/journal.pone.0024413.
   Web of Science ®Google Scholar
• Rimmelzwaan GF, Baars M, Van Amerongen G, Van Beek R, Osterhaus ADME. A single dose of an ISCOM influenza vaccine induces long-lasting protective immunity against homologous challenge infection but fails to protect Cynomolgus macaques against distant drift variants of influenza A (H3N2) viruses. Vaccine. 2001;20:158–63. doi:10.1016/S0264-410X(01)00262-6. PMID:11567760
   PubMed Web of Science ®Google Scholar
• Pun PB, Bhat AA, Mohan T, Kulkarni S, Paranjape R, Rao DN. Intranasal administration of peptide antigens of HIV with mucosal adjuvant CpG ODN coentrapped in microparticles enhances the mucosal and systemic immune responses. Int Immunopharmacol. 2009;9:468–77. doi:10.1016/j.intimp.2009.01.012. PMID:19291836
   PubMed Web of Science ®Google Scholar
• Callahan PM, Shorter AL, Hem SL. The Importance of Surface Charge in the Optimization of Antigen–Adjuvant Interactions. Pharm Res An Off J Am Assoc Pharm Sci. 1991;8:851–8.
   Google Scholar
• Seeber SJ, White JL, Hem SL. Predicting the adsorption of proteins by aluminium-containing adjuvants. Vaccine. 1991;9:201–3. doi:10.1016/0264-410X(91)90154-X. PMID:2042392
   PubMed Web of Science ®Google Scholar
• Liu JCC, Joseph R, Feldkamp JL, White, Stanley LH. Adsorption of Phosphate by Aluminum Hydroxycarbonate. J Pharm Sci 1984;10:1355–58. doi:10.1002/jps.2600731007.
   Google Scholar
• Song J, Willinger T, Rongvaux A, Eynon EE, Stevens S, Manz MG, Flavell RA, Galan JE. A mouse model for the human pathogen Salmonella typhi. Cell Host Microbe. 2010;4:369–376. doi:10.1016/j.chom.2010.09.003.
   Google Scholar
• Marshall JL, Flores-Langarica A, Kingsley RA, Hitchcock JR, Ross EA, Lopez-Macias C, et al. The Capsular Polysaccharide Vi from Salmonella Typhi Is a B1b Antigen. J Immunol. 2012;189:5527–32. doi:10.4049/jimmunol.1103166. PMID:23162127
   PubMed Web of Science ®Google Scholar
• Higginson EE, Simon R, Tennant SM. Animal models for salmonellosis: Applications in vaccine research. Clin Vaccine Immunol. 2016;23:746–56. doi:10.1128/CVI.00258-16. PMID:27413068
   PubMed Web of Science ®Google Scholar
• Kossaczka, Zuzana, Slavomir B, Dolores AB, Joseph S, John BR, Shousun CS. Synthesis and Immunological Properties of Vi and Di-O-Acetyl Pectin Protein Conjugates with Adipic Acid Dihydrazide as the Linker. Infect Immun 1997;6:2088–93.
   Google Scholar
• Hestrin S. The reaction of acetylcholine and other carboxylic acid derivatives with hydroxylamine and its analytical applications. J. Biol. Chem 1949;180: 249–261
   PubMed Web of Science ®Google Scholar
• Micoli F, Rondini S, Pisoni l. Vi-CRM(197) as a new conjugate vaccine against Salmonella Typhi. Vaccine. 2011;29:712–720. doi:10.1016/j.vaccine.2010.11.022.
   PubMed Web of Science ®Google Scholar
• Bowman FW, Calhoun MP, White M. Microbiological methods for quality control of membrane filters. J Pharm Sci. 1967;56:222–225. doi:10.1002/jps.2600560214. PMID:5337945
   PubMed Web of Science ®Google Scholar
• Lin FYC, Ho VA, Bay P V, Thuy NTT, Bryla D, Thanh TC, Khiem HB, Trach DD, Robbins JB. The epidemiology of typhoid fever in the Dong Thap Province, Mekong Delta region of Vietnam. Am J Trop Med Hyg. 2000;62:644–8. doi:10.4269/ajtmh.2000.62.644. PMID:11289678
   PubMed Web of Science ®Google Scholar
• Cui C, Carbis R, An SJ, Jang H, Czerkinsky C, Szu SC, Clemens JD. Physical and chemical characterization and immunologic properties of Salmonella enterica serovar typhi capsular polysaccharide-diphteria toxoid conjugates. Clin Vaccine Immunol. 2010;17:73–9. doi:10.1128/CVI.00266-09. PMID:19889941
   PubMed Web of Science ®Google Scholar